Complications of intravitreal injections: 2022

D Patel, SN Patel, V Chaudhary… - Current Opinion in …, 2022 - journals.lww.com
Intravitreal injections continue to be one of the most commonly performed procedures by
ophthalmologists. Although the injections are generally well tolerated, sight-threatening …

Challenges and opportunities for drug delivery to the posterior of the eye

FJ Cabrera, DC Wang, K Reddy, G Acharya… - Drug discovery today, 2019 - Elsevier
Highlights•The development of efficacious ocular drug delivery systems to treat diseases of
the back of the eye faces many challenges due to the unique anatomy and physiology of the …

Preventive factors, diagnosis, and management of injection-related endophthalmitis: a literature review

R Singh, S Davoudi, S Ness - Graefe's Archive for Clinical and …, 2022 - Springer
Background Intravitreal medication injections represent the gold standard treatment for a
variety of potentially blinding chorioretinal vascular diseases. Despite their excellent safety …

Prophylaxis measures for postinjection endophthalmitis

SN Patel, S Gangaputra, P Sternberg Jr, SJ Kim - Survey of Ophthalmology, 2020 - Elsevier
Intravitreal injections have become the most commonly performed ophthalmic procedure,
transforming modern retina practice. Postinjection endophthalmitis, while rare, remains the …

Safety of receiving anti–vascular endothelial growth factor intravitreal injection in office-based vs operating room settings: a meta-analysis

T Li, J Sun, J Min, S Zhou, X Zhu, H Jia… - JAMA …, 2021 - jamanetwork.com
Importance Compared with the operating room (OR), office-based intravitreal injection (IVI)
is considered a more cost-effective and convenient approach, yet clinical outcomes of IVIs …

[HTML][HTML] Pyruvate-conjugation of PEGylated liposomes for targeted drug delivery to retinal photoreceptors

G Christensen, Y Chen, D Urimi, L Zizmare… - Biomedicine & …, 2023 - Elsevier
Despite several promising candidates, there is a paucity of drug treatments available for
patients suffering from retinal diseases. An important reason for this is the lack of suitable …

Same-day bilateral intravitreal anti-vascular endothelial growth factor injections: experience of a large Canadian retina center

VR Juncal, CLM Francisconi, F Altomare, DR Chow… - …, 2019 - karger.com
Objective: To evaluate the outcomes and complications of bilateral same-day intravitreal anti-
vascular endothelial growth factor (anti-VEGF) injections. Methods: This is a single-center …

Bilateral blindness after uneventful brolucizumab injection for macular degeneration

I Barchichat, M Thiel, O Job, M Schmid - BMC ophthalmology, 2022 - Springer
Background We report a very severe case of bilateral panuveitis and ischemic vasculitis with
possible perineural inflammation, which followed bilateral intravitreal brolucizumab …

Postoperative endophthalmitis—a review of literature

L Bisorca-Gassendorf, KT Boden, P Szurman… - Der …, 2021 - Springer
Die postoperative Endophthalmitis bleibt eine der gefürchtetsten Komplikationen und
Notfallsituationen für Augenärzte, obwohl ein unverzügliches therapeutisches Einschreiten …

Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents

PP Storey, D Patel, S Garg - Canadian Journal of Ophthalmology, 2020 - Elsevier
Although intravitreal injections of anti-vascular endothelial growth factor medications are
generally safe and effective, endophthalmitis remains a rare but potentially devastating …